Subscribe to RSS
DOI: 10.1055/s-0029-1185972
© Georg Thieme Verlag KG Stuttgart · New York
Activity of Ladanein on Leukemia Cell Lines and Its Occurrence in Marrubium vulgare
Publication History
received March 24, 2009
revised June 17, 2009
accepted June 21, 2009
Publication Date:
30 July 2009 (online)
![](https://www.thieme-connect.de/media/plantamedica/201001/lookinside/thumbnails/10.1055-s-0029-1185972-1.jpg)
Abstract
Three methoxylated flavones isolated from Marrubium peregrinum – ladanein, scutellarein-5,7,4′-trimethyl ether, and scutellarein-5,6,7,4′-tetramethyl ether – were assayed for their cytotoxicity towards a recently developed dasatinib-resistant murine leukemia cell line (DA1-3b/M2BCR‐ABL), together with the structurally related non-methylated flavone scutellarein. The most active compound, ladanein, was looked for in 20 common Lamiaceae species by a quick HPLC screening. Among the possible positive results, the most interesting source was found to be Marrubium vulgare, which led to the isolation and identification of ladanein for the first time in this species. Ladanein also displayed moderate (20–40 µM) activities against K562, K562R (imatinib-resistant), and 697 human leukemia cell lines but was toxic neither to MOLM13 nor to human peripheral blood mononuclear cells. This work provides a common natural source for the hemi-synthesis of future ladanein-derived flavones and the study of their antileukemic activity.
Key words
Marrubium - Lamiaceae - ladanein - leukemia - DA1‐3b/M2BCR‐ABL - K562 - MOLM13–97
References
- 1 Treuil P. La leucémie myéloïde chronique et son traitement par l'imatinib. Actual Pharm. 2008; 473 25-30
- 2 Buxeraud J, Skrzypek A. Médicaments sortant de la réserve hospitalière, Sprycel® – dasatinib. Actual Pharm. 2008; 471 49-52
- 3 Faure S. Un nouvel inhibiteur de tyrosine kinase. Actual Pharm. 2008; 473 8
- 4 Alkhatib R, Hennebelle T, Joha S, Idziorek T, Preudhomme C, Quesnel B, Sahpaz S, Bailleul F. Activity of elaeochytrin A from Ferula elaeochytris on leukemia cell lines. Phytochemistry. 2008; 69 2979-2983
- 5 Haïdara K, Zamir L, Shi Q W, Batist G. The flavonoid casticin has multiple mechanisms of tumor cytotoxicity action. Cancer Lett. 2006; 242 180-190
- 6 Li-Weber M. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents wogonin, baicalein and baicalin. Cancer Treat Rev. 2009; 35 57-68
- 7 Hennebelle T, Skaltsounis A L, Sahpaz S, Bailleul F. Phenolic compounds and diterpenoids from Marrubium peregrinum. Biochem Syst Ecol. 2007; 35 624-626
- 8 Tezuka Y, Stampoulis P, Banskota A H, Awale S, Tran K Q, Saiki I, Kadota S. Constituents of the Vietnamese medicinal plant Orthosiphon stamineus. Chem Pharm Bull. 2000; 48 1711-1719
- 9 Seo J M, Kang H M, Son K H, Kim J H, Lee C W, Kim H M, Chang S I, Kwon B M. Antitumor activity of flavones isolated from Artemisia argyi. Planta Med. 2003; 69 218-222
-
10 Wollenweber E.
Flavones and flavonols. Harborne JB The flavonoids – advances in research since 1986. Cambridge; Chapman & Hall 1994: 259-335 - 11 Tóth E, Tóth G, Máthé I, Blunden G. Martynoside, forsythoside B, ladanein and 7α-acetoxyroyleanone from Ballota nigra L. Biochem Syst Ecol. 2007; 35 894-897
- 12 Pocaly M, Lagarde V, Etienne G, Dupouy M, Lapaillerie D, Claverol S, Vilain S, Bonneu M, Turcq B, Mahon F X, Pasquet J M. Proteomic analysis of an imatinib-resistant K562 cell line highlights opposing roles of heat shock cognate 70 and heat shock 70 proteins in resistance. Proteomics. 2008; 8 2394-2406
- 13 Liu J, Joha S, Idziorek T, Corm S, Hetuin D, Philippe N, Preudhomme C, Quesnel B. BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism. Leukemia. 2008; 22 791-799
Dr. Thierry Hennebelle
Faculté des Sciences Pharmaceutiques et Biologiques
Laboratoire de Pharmacognosie, Université de Lille 2
59006 Lille
France
Phone: + 33 3 20 96 40 39,
Fax: + 33 3 20 96 40 39
Email: thierry.hennebelle@univ-lille2.fr